Abstract
NanoString nCounter is a multiplex nucleic acid hybridization technology that enables reliable and reproducible assessment of the expression of up to 800 genes or 228 gene fusions in 12 samples in a single assay. The technique works well with a variety of starting materials from fresh or formalin-fixed tissues, cell lysates or biological fluid samples. As low as 1 ng RNA input per sample is needed. In addition to gene expression, copy number variation, single nucleotide variation and chimeric RNAs can be analyzed. In this chapter, we discuss the design, setup, and performance of a NanoString-based RNA assay for gene expression or fusion transcript assessment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NanoString Technologies (2003) https://www.NanoString.com/. Accessed January 2019
Wallden B, Storhoff J, Nielsen T, Dowidar N et al (2015) Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med Genet 8:54–68. https://doi.org/10.1186/s12920-015-0129-6
Lira ME, Choi YL, Lim SM, Deng S et al (2014) A single-tube multiplex assay for detecting ALK, ROS1, and RET fusions in lung cancer. J Mol Diagn 16(2):229–243. https://doi.org/10.1016/j.jmoldx.2013.11.007
Hu D, Zhou W, Wang F, Shu SM et al (2016) Development of a NanoString assay to detect leukemogenic fusion transcripts in acute myeloid leukemia. Int J Lab Hematol 38(6):663–673. https://doi.org/10.1111/ijlh.12555
Scott DW, Abrisqueta P, Wright GW, Slack GW et al (2017) New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies. J Clin Oncol 35(15):1668–1677. https://doi.org/10.1200/JCO.2016.70.7901
Chang KTE, Goytain A, Tucker T, Karsan A et al (2018) Development and evaluation of a Pan-Sarcoma fusion gene detection assay using the NanoString nCounter platform. J Mol Diagn 20(1):63–77. https://doi.org/10.1016/j.jmoldx.2017.09.007
Geiss GK, Bumgardner RE, Birditt B, Dahl T et al (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26(3):317–326
Parker JS, Mullins M, Cheang MC et al (2009) Supervised risk factor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167
Veldman-Jones MH, Brant R, Rooney C et al (2015) Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res 75(13):2587–2593. https://doi.org/10.1158/0008-5472.CAN-15-0262
ThermoFisher Scientific—Qubit (2016) https://www.thermofisher.com/ca/en/home/industrial/spectroscopy-elemental-isotope-analysis/molecular-spectroscopy/fluorometers/qubit/. Accessed January 2019
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Goytain, A., Ng, T. (2020). NanoString nCounter Technology: High-Throughput RNA Validation. In: Li, H., Elfman, J. (eds) Chimeric RNA. Methods in Molecular Biology, vol 2079. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9904-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9904-0_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9903-3
Online ISBN: 978-1-4939-9904-0
eBook Packages: Springer Protocols